azd8701
Showing 1 - 1 of 1
Clear Cell Renal Cell Cancer, Non-Small-Cell Lung Cancer, Triple Negative Breast Tumors Trial in Worldwide (AZD8701, Durvalumab)
Recruiting
- Clear Cell Renal Cell Cancer
- +8 more
- AZD8701
- Durvalumab
-
La Jolla, California
- +22 more
Aug 12, 2022